The clinical trials below are available in the specialty you selected. Choose a different specialty.

Adult ADHD Medication Study
A nationwide research study of a new investigational drug for adults with ADHD. Duke University Medical Center in Durham, NC, will conduct this study. Study-related evaluations and study drug will be provided at no cost to those who qualify. (REF# 00042466)

Nicotine, Non-Smokers with and without ADHD, and Genetics Study (NNSG)
The main purpose of the NNSG study is to evaluate the effects of nicotine exposure in a group of nonsmoking young adults with and without ADHD. (REF# Pro00037792)

ADHD Adolescent Medication Study
We are looking for adolescents 13-17 years old who may have ADHD to participate in a nationwide research study testing two FDA approved drugs for ADHD. ADHD evaluation and study drug will be provided at no cost to those who qualify. (REF# 00038164)

Emotion Dysregulation in ADHD and non-ADHD smokers
The purpose of this study is to examine the association between emotion dysregulation and smoking cigarette smoking in attention deficit and hyperactivity disorder (ADHD) smokers and non-ADHD smokers. (REF# Pro00034996)

Neurobiology of Response Inhibition in Comorbid ADHD and Nicotine Dependence
This study seeks adult smokers with and without ADHD. (REF# 9085)